Copyright © 1998 by the European Society of Cardiology.
Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients
a Department of Cardiology and Angiology, University Hospital, Gent, Belgium
b Cardiovascular Division, Department of Medicine, University of Minnesota, Medical School, Minneapolis, U.S.A.
accepted April 14, 1998
Aims
The purpose of this study was to examine, in chronically treated heart failure patients vs control subjects, the influence of neurohumoral activation and aldosterone escape on arterial elastic behaviour, assessed by non-invasive mathematical lumped-parameter modelling of the compliance of the arterial system.
Methods and Results
Radial arterial pulse waves were recorded non-invasively for 30s with an arterial tonometer sensor array in 13 chronic heart failure patients (mean age, 59±2·5 years) in New York Heart Association class II. The patients had been taking digoxin, furosemide, captopril and aspirin for more than 3 months. Thirteen healthy subjects (mean age, 50±4·0 years) acted as controls. Compliance of the proximal (aorta and major branches, C1) and distal parts (C2) of the circulation were derived from a third order four-element modified Windkessel model which can reproduce arterial pressure waveforms, including both exponential and oscillatory sections. Active renin, angio-tensin II and aldosterone levels were determined on venous blood samples in the supine position and after 30min active standing. There was decreased proximal (C1, 1·51±0·11ml.mmHg–1,P<0·01) and distal (C2, 0·050±0·011ml.mmHg–1) arterial compliance in the chronic heart failure patients vs controls (C1, 1·71±0·16ml.mmHg–1; C2, 0·054±0·006ml.mmHg–1). The chronic heart failure patients were characterized by an aldosterone escape phenomenon which was inversely correlated with the proximal arterial compliance in both supine (r=–0·795,P=0·002) and standing (r=–0·628,P=0·029) positions.
Conclusions
In chronically treated heart failure patients with full angiotensin-converting enzyme-inhibition and diuretics, there is decreased compliance of the aorta and its major branches, which is inversely correlated with the aldosterone escape phenomenon.
Key Words: ACE-inhibition • arterial compliance • chronic heart failure • conduit arteries • renin-angiotensin-aldosterone system
f1 Correspondence:Prof. Dr D. Duprez, Department of Cardiology-Angiology, University Hospital, De Pintelaan 185, B-9000 Gent, Belgium.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Bansal, J. Lindenfeld, and R. W. Schrier Sodium Retention in Heart Failure and Cirrhosis: Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist? Circ Heart Fail, July 1, 2009; 2(4): 370 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF]
|
|
|
|
 |
|
 2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Maron, Y.-Y. Zhang, D. E. Handy, A. Beuve, S.-S. Tang, J. Loscalzo, and J. A. Leopold Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells J. Biol. Chem., March 20, 2009; 284(12): 7665 - 7672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, I. Stefanon, and J. Bauersachs Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction Hypertension, November 1, 2007; 50(5): 919 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Bobadilla and G. Gamba New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone Am J Physiol Renal Physiol, July 1, 2007; 293(1): F2 - F9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gros, Q. Ding, S. Armstrong, C. O'Neil, J. G. Pickering, and R. D. Feldman Rapid effects of aldosterone on clonal human vascular smooth muscle cells Am J Physiol Cell Physiol, February 1, 2007; 292(2): C788 - C794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Beygui, J.-P. Collet, J.-J. Benoliel, N. Vignolles, R. Dumaine, O. Barthelemy, and G. Montalescot High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction Circulation, December 12, 2006; 114(24): 2604 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C Shah, S. Pringle, and A. Struthers Aldosterone Blockade Over and Above ACE-Inhibitors in Patients with Coronary Artery Disease but without Heart Failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1): 20 - 30. [Abstract] [PDF]
|
|
|
|
|
|
J. Blanco-Rivero, V. Cachofeiro, V. Lahera, R. Aras-Lopez, I. Marquez-Rodas, M. Salaices, F. E. Xavier, M. Ferrer, and G. Balfagon Participation of Prostacyclin in Endothelial Dysfunction Induced by Aldosterone in Normotensive and Hypertensive Rats Hypertension, July 1, 2005; 46(1): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Milliez, X. Girerd, P.-F. Plouin, J. Blacher, M. E. Safar, and J.-J. Mourad Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1243 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Connell Review: Aldosterone -- the future challenge in cardiovascular disease? The British Journal of Diabetes & Vascular Disease, November 1, 2004; 4(6): 370 - 376. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Giannattasio, F. Achilli, M. Failla, A. Capra, A. Vincenzi, G. Gentile, D. Corsi, C. Zazzeron, L. Turolo, A. Morganti, et al. Arterial stiffness in heart failure patients: dependance on diastolic dysfunction and plasma aldosterone levels Eur. Heart J. Suppl., November 1, 2004; 6(suppl_F): F30 - F34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Struthers The clinical implications of aldosterone escape in congestive heart failure Eur J Heart Fail, August 1, 2004; 6(5): 539 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pitt Generic drugs in cardiology: will they reduce health care costs? J. Am. Coll. Cardiol., July 7, 2004; 44(1): 10 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Nishizaka, M. A. Zaman, S. A. Green, K. Y. Renfroe, and D. A. Calhoun Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism Circulation, June 15, 2004; 109(23): 2857 - 2861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fletcher, A. N. Buch, H. C. Routledge, S. Chowdhary, J. H. Coote, and J. N. Townend Acute aldosterone antagonism improves cardiac vagal control in humans J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1270 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. K Shieh, E. Kotlyar, and F. Sam Aldosterone and cardiovascular remodelling: focus on myocardial failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 3 - 13. [Abstract] [PDF]
|
|
|
|
 |
|
 A. D Struthers and T. M MacDonald Review of aldosterone- and angiotensin II-induced target organ damage and prevention Cardiovasc Res, March 1, 2004; 61(4): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Safar, A. Avolio, W. B. White, and D. Duprez Letter: Aldosterone Antagonism and Arterial Stiffness Hypertension, February 1, 2004; e3(2): . [Full Text] [PDF]
|
|
|
|
|
|
S. L. Liu, S. Schmuck, J. Z. Chorazcyzewski, R. Gros, and R. D. Feldman Aldosterone Regulates Vascular Reactivity: Short-Term Effects Mediated by Phosphatidylinositol 3-Kinase-Dependent Nitric Oxide Synthase Activation Circulation, November 11, 2003; 108(19): 2400 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Domanski, J. Norman, B. Pitt, M. Haigney, S. Hanlon, and E. Peyster Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD) J. Am. Coll. Cardiol., August 20, 2003; 42(4): 705 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. White, D. Duprez, R. St Hillaire, S. Krause, B. Roniker, J. Kuse-Hamilton, and M. A. Weber Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension Hypertension, May 1, 2003; 41(5): 1021 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 19, 2003; 41(4): 574 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lacolley, C. Labat, A. Pujol, C. Delcayre, A. Benetos, and M. Safar Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt-Treated Rats: Effects of Eplerenone Circulation, November 26, 2002; 106(22): 2848 - 2853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Spironolactone Improves Cardiac Sympathetic Nerve Activity and Symptoms in Patients with Congestive Heart Failure J. Nucl. Med., October 1, 2002; 43(10): 1279 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gunaruwan, M. Schmitt, J. Taylor, L. Lee, A. Struthers, and M. Frenneaux Lack of rapid aldosterone effects on forearm resistance vasculature in health Journal of Renin-Angiotensin-Aldosterone System, June 1, 2002; 3(2): 123 - 125. [Abstract] [PDF]
|
|
|
|
|
|
C. Giannattasio, F. Achilli, M. Failla, A. Capra, A. Vincenzi, F. Valagussa, and G. Mancia Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1275 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D Struthers Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 211 - 214. [PDF]
|
|
|
|
 |
|
 J. Takaya, T. Matsusaka, H. Katori, M. Tamura, Y. Miyazaki, T. Homma, and I. Ichikawa In Situ Demonstration of Angiotensin-Dependent and Independent Pathways for Hyperaldosteronism During Chronic Extracellular Fluid Volume Depletion Mol. Endocrinol., December 1, 2001; 15(12): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. J. Farquharson and A. D. Struthers Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart Failure Circulation, February 15, 2000; 101(6): 594 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pitt, F. Zannad, W. J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes, and The Randomized Aldactone Evaluation Study Investig The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure N. Engl. J. Med., September 2, 1999; 341(10): 709 - 717. [Abstract] [Full Text] [PDF]
|
|